Insights
Who can put a price on cell and gene therapy?
Insights from the Endpoints UK Biotech Summit October 2019 Fifteen years ago, Health Economics Outcomes Research (HEOR) was the pharma industry’s new kid on...
RSA Talent Talks debut Podcast
We’re seeing some of the most exciting new therapeutics emerge from the Cell & Gene Therapy Sector, it’s happening quickly and delivering meaningful results...